SACCO, RODOLFO, COSMA, DAMIANO
 Distribuzione geografica
Continente #
NA - Nord America 2.588
EU - Europa 1.987
AS - Asia 1.649
SA - Sud America 243
Continente sconosciuto - Info sul continente non disponibili 103
AF - Africa 24
OC - Oceania 2
Totale 6.596
Nazione #
US - Stati Uniti d'America 2.545
CN - Cina 575
SG - Singapore 534
IE - Irlanda 516
UA - Ucraina 315
SE - Svezia 311
RU - Federazione Russa 303
BR - Brasile 195
VN - Vietnam 163
IT - Italia 127
HK - Hong Kong 124
IN - India 106
DE - Germania 105
FR - Francia 87
GB - Regno Unito 85
FI - Finlandia 82
TR - Turchia 63
CA - Canada 21
AR - Argentina 17
BE - Belgio 17
MX - Messico 12
EU - Europa 11
BD - Bangladesh 10
CO - Colombia 10
TW - Taiwan 10
JP - Giappone 8
IQ - Iraq 7
PL - Polonia 7
ZA - Sudafrica 7
EC - Ecuador 6
ID - Indonesia 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
ES - Italia 5
PH - Filippine 5
VE - Venezuela 5
AL - Albania 4
AT - Austria 4
MA - Marocco 4
PK - Pakistan 4
SA - Arabia Saudita 4
DO - Repubblica Dominicana 3
KE - Kenya 3
KR - Corea 3
KZ - Kazakistan 3
PY - Paraguay 3
TN - Tunisia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
IR - Iran 2
NL - Olanda 2
OM - Oman 2
PA - Panama 2
SN - Senegal 2
AU - Australia 1
BG - Bulgaria 1
BW - Botswana 1
CH - Svizzera 1
CR - Costa Rica 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KY - Cayman, isole 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
TH - Thailandia 1
UY - Uruguay 1
Totale 6.504
Città #
Dublin 515
San Jose 420
Chandler 323
Singapore 269
Jacksonville 220
Nyköping 195
Beijing 148
Dearborn 148
Ashburn 146
Hong Kong 124
Nanjing 114
Wilmington 93
Dong Ket 75
Santa Clara 66
Ann Arbor 65
Council Bluffs 59
New York 55
San Mateo 54
Princeton 53
Lauterbourg 52
Woodbridge 50
Moscow 49
Columbus 47
Nanchang 38
Helsinki 35
Dallas 32
Boardman 31
Munich 31
Ho Chi Minh City 29
Philadelphia 28
Hanoi 24
Cedar Knolls 23
Shenyang 23
Los Angeles 21
Tianjin 20
Changsha 19
Stevenage 19
São Paulo 18
Brussels 17
Jiaxing 17
Hebei 16
Des Moines 13
Kunming 13
Hilden 12
Guangzhou 10
Banqiao 9
Bari 9
Belo Horizonte 9
Hangzhou 9
Rio de Janeiro 9
Toronto 9
Brasília 8
Chicago 8
Foggia 8
Milan 8
Nuremberg 8
Orem 8
Rome 7
Shanghai 7
Changchun 6
Chennai 6
Frankfurt am Main 6
Kocaeli 6
Las Vegas 6
London 6
Ningbo 6
The Dalles 6
Tokyo 6
Auburn Hills 5
Borås 5
Curitiba 5
Da Nang 5
Leawood 5
Porto Alegre 5
Warsaw 5
Augusta 4
Brooklyn 4
Cluj 4
Fairfield 4
Hillsboro 4
Houston 4
Jinan 4
Johannesburg 4
Ninh Bình 4
Pune 4
San Francisco 4
Seattle 4
Taizhou 4
Turku 4
Zhengzhou 4
Asunción 3
Baghdad 3
Buffalo 3
Campo Grande 3
Can Tho 3
Charlotte 3
Lanzhou 3
Manchester 3
New Delhi 3
Orange 3
Totale 4.124
Nome #
Chemioembolizzazione con particelle embolizzanti a rilascio farmacologico (DEB-TACE) vs tecnica convenzionale (TACE): risposta tumorale e sopravvivenza in pazienti con HCC 265
228 CONVENTIONAL TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (C-TACE) VERSUS DOXORUBICIN ELUTING BEAD (DEB)-TACE FOR HEPATOCELLULAR CARCINOMA: ASSESSMENT OF CLINICAL IMPACT-SHORT AND LONG-TERM PROSPECTIVE STUDY 230
392 HBeAg defective mutants in active/inactive anti-HBe positive HBV carriers: Possible role of pre-core initiation mutants 172
526 Liver stiffness measured by transient elastography. The influence of biochemical activity 164
The tightly regulated inducible expression of the core protein of hepatitis C virus modulates Fas- and TNF alpha-mediated apoptosis in human liver cells 159
[GLUTATHIONE IN THE TREATMENT OF CHRONIC FATTY LIVER DISEASES] 156
504 HBV quasispecies selected during lamivudine treatment may contribute to adefovir dipivoxil resistance 153
Cost effective prediction of sustained response to IFN Alfa-2B or PEG-IFN Alfa 2B plus Ribavirin computing infected cells dynamics by early ALT and HCV-RNA decline 138
Antiapoptotic regulation by hepatitis C virus core protein through up-regulation of inhibitor of caspase-activated DNase. 133
HBeAg defective mutants in active/inactive anti-HBe positive HBsAg carriers: possible role of pre-core initiation mutants 132
Transient elastography improves the management of CHB patients 132
Early prediction of sustained response in chronic hepatitis C patients treated with pegilated IFNs (A-2B or A-2A) plus ribavirin using a bio-mathematical model that describes the dynamics of infected cells 132
Complete response for advanced liver cancer during sorafenib therapy: case report. 129
Survival after transarterial chemoembolization in early-stage HCC patients excluded from liver transplantation: a prospective cohort study 128
Liver inflammation and acute respiratory distress syndrome in a patient receiving hepatitis B vaccine: a possible relationship? 127
EARLY AND COST EFFECTIVE PREDICTION OF TREATMENT OUTCOME WITH IFNA2B OR PEG-IFNA2B PLUS RIBAVIRIN COMPUTING INFECTED CELLS DYNAMICS BY ALT AND HCV-RNA DECLINE DURING THE FIRST MONTH 125
Hepatitis C virus serotypes in haemodialysis patients in South-East Italy. 123
Entecavir for Hepatitis B Virus Flare Treatment in Patients with Crohn’s Disease 122
Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: a cohort study 122
Selective transcatheter arterial chemoembolization for hepatocellular carcinoma: Evaluation of clinical impact-short and long-term prospective study 121
Liver stiffness measured by transient elastography: The influence of biochemical activity 120
Hepatitis C virus serotypes and sources of infection in patients with HCV-related chronic liver disease from one geographical area in southeast Italy. 118
Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma. 118
Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment. 115
Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. 115
Pulmonary or otolaryngologic extraesophageal manifestations in patients with gastroesophageal reflux disease 114
Feasibility and safety of granulocytapheresis in Crohn’s disease: A prospective color study 113
Distribution of hepatitis C virus serotypes and duration of infection in HCV infected subjects from a geographical area in Southeast Italy. 112
The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease. 111
sICAM-1, sCD95 and sCD95L levels in chronic liver diseases of different etiology. 111
MONITORING LIVER STIFFNESS: A NEW TOOL TO MEASURE LIVER FIBROSIS DURING THERAPY 111
Conventional vs Doxorubicin Eluting Bead Transcatheter Chemoembolization for Hepatocellular Carcinoma. 111
Monitoring liver elasticity: a new tool to measure liver fibrosis during therapy 107
Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients. 106
Efficacy of hemostatic powders in lower gastrointestinal bleeding: Clinical series and literature review 106
A new model of HBV infection dynamics shows a multiphasic decay of viral load and a short half-life of circulating virus in anti-HBe positive patients treated with lamivudine 104
Adherence to AASLD guidelines in the real world of HCC in Italy preliminary results of a prospective study 102
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 99
Endotics system versus colonscopy for the detection of polyps a randomised trial 99
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study. 96
Quantitative Determination of Hepatitis C Core Antigen in Therapy Monitoring for Chronic Hepatitis C. 92
TRANS-TACE: Prognostic Role of the Transient Hypertransaminasemia after Conventional Chemoembolization for Hepatocellular Carcinoma 91
Effectiveness of hemostatic powders in lower gastrointestinal bleeding: a systematic review and meta-analysis 90
Partial Response and Cardiovascular Recovery after Sorafenib Dose Reduction in a Multinodular HCC Patient. 87
Utilization of Hepatocellular Carcinoma Surveillance Programs in Patients With Cirrhosis: A Systematic Review and Meta-Analysis 85
Endotics system vs colonoscopy for the detection of polyps 84
Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma 84
Valutazione dell’impatto sulla funzionalità epatica della chemioembolizzazione in pazienti con epatocarcinoma tecnica convenzionale Versus particelle embolizzanti. 80
Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysis 78
Bright Luminal Sign on High b-Value Diffusion-Weighted Magnetic Resonance Enterography Imaging as a New Biomarker to Predict Fibrotic Strictures in Crohn’s Disease Patients: A Retrospective Preliminary Study 77
Towards a tailored systemic therapy for liver cancer 75
Sustained response to Interferon-ribavirin combination therapy in chronich hepatitis C predicted by a model of viral dynamics using both HCV-RNA and alanine amino transferase. 74
Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review 60
Cholangiocarcinoma in the Era of Immunotherapy 59
Prognostic Role of Post-Induction Fecal Calprotectin Levels in Patients with Inflammatory Bowel Disease Treated with Biological Therapies 59
Microwave Ablation Versus Radiofrequency Ablation for Treatment of Hepatocellular Carcinoma: A Meta-Analysis of Randomized Controlled Trials 59
Stereotactic body radiotherapy vs radiofrequency ablation for the treatment of hepatocellular carcinoma: a meta-analysis 59
Target therapies plus somatostatin analogues in NETs: a network meta-analysis 52
Reply to Lissing et al. Comment on "Ramai et al. Risk of Hepatocellular Carcinoma in Patients with Porphyria: A Systematic Review. Cancers 2022, 14, 2947" 46
An Unusual Case of Herpes Zoster of the Hand Following a Physical Trauma: Case Report and Literature Review 34
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 20
Totale 6.596
Categoria #
all - tutte 32.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.290


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022312 0 4 9 8 54 25 16 21 47 37 7 84
2022/20231.416 116 79 82 112 71 124 6 133 620 10 40 23
2023/2024183 42 14 4 4 16 62 2 5 2 14 1 17
2024/2025894 36 7 12 28 61 103 89 50 286 42 80 100
2025/20261.706 110 99 194 210 132 103 382 195 81 101 56 43
2026/2027156 38 118 0 0 0 0 0 0 0 0 0 0
Totale 6.596